CD4 and neoplasm: Our in vivo experiment further suggested that the targeted silence of CRNDE-h in CD4+ T cells reduced the Th17 cell proportion in the tumor-infiltrating T cells and inhibited the tumor growth in the tumor-transplanted mice.